NNKTT120, an anti-iNKT cell monoclonal antibody, produces rapid and sustained iNKT cell depletion in adults with sickle cell disease.
Invariant NKT (iNKT) cells can be activated to stimulate a broad inflammatory response. In murine models of sickle cell disease (SCD), interruption of iNKT cell activity prevents tissue injury from vaso-occlusion. NKTT120 is an anti-iNKT cell monoclonal antibody that has the potential to rapidly and...
Saved in:
| Main Authors: | Joshua J Field, Elaine Majerus, Kenneth I Ataga, Elliot P Vichinsky, Robert Schaub, Robert Mashal, David G Nathan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2017-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0171067&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MAIT and iNKT cells in tissue homeostasis and repair
by: Rafael Almeida Paiva, et al.
Published: (2025-05-01) -
CAR-iNKT cells: redefining the frontiers of cellular immunotherapy
by: Magdalena Niedzielska, et al.
Published: (2025-07-01) -
The Ras/MAPK pathway is required for generation of iNKT cells.
by: Taishan Hu, et al.
Published: (2011-05-01) -
Global trends and frontiers in iNKT cells: a bibliometric and visualized analysis
by: Dan Zhang, et al.
Published: (2025-07-01) -
Single-cell transcriptomic profiling reveals diversity in human iNKT cells across hematologic tissues
by: Reyka G. Jayasinghe, et al.
Published: (2025-05-01)